Mr. Geoffrey Parker

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Menlo Park, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Diana Witt, attorney-in-fact for Mr. Geoffrey Parker
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mr. Geoffrey Parker

Form 4 holding Director

Better Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,031,805
Estimated value
$175,304
Report date
18 Dec 2023
Price
$0.1699
Ownership
Direct
Form 4 holding Director

Better Therapeutics, Inc.

Security class
Common Stock
Shares / value
53,333
Estimated value
$9,061
Report date
18 Dec 2023
Price
$0.1699
Ownership
By Parker Trust
Form 4 holding COO, CFO and EVP

Tricida, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
256,000
Estimated value
Report date
28 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
$50.95
Ownership
By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
$50.95
Ownership
Direct
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
$50.95
Ownership
Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Stock Option
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

PERRIGO Co plc

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
12 Jun 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Mr. Geoffrey Parker

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .